Human epidermal growth factor receptor 2-positive metastatic gastric cancer in complete sustained remission with trastuzumab. O'Mahony D, Power SP, Power DG. Lancet 2023;401:772.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

O'Mahony D, Power SP, Power DG. Human epidermal growth factor receptor 2-positive metastatic gastric cancer in complete sustained remission with trastuzumab. Lancet 2023;401:772.
PMID: 36870727